Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

A Novel Fusion Gene NDEL1-Pdgfrb in a Patient with JMML with a New Variant of TKI-Resistant Mutation in the Kinase Domain of PDGFRβ

Konstantin Byrgazov, PhD, Renate Kastner, PhD, Michael Dworzak, MD, Gregor Hoermann, MD PhD, Oskar A. Haas, MD, Raphael Ulreich, MD, Christian E. Urban, MD, Oliver D. Hantschel, PhD, Peter Valent, MD, Thomas Lion, MD PhD

Blood (2014) 124 (21): 613.

https://doi.org/10.1182/blood.V124.21.613.613

Published: 2014

Journal Articles

Rapid Identification Of Compound Mutations In Patients With Ph-Positive Leukemias By Long-Range Next Generation Sequencing

Sandra Preuner, MSc, Renate Kastner, Agnes Zopf, MSc, Proell Johannes, PhD, Pierre Foskett, PhD, Peter Valent, Christian Gabriel, MD, Thomas Lion, MD, PhD

Blood (2013) 122 (21): 1373.

https://doi.org/10.1182/blood.V122.21.1373.1373

Published: 2013

Journal Articles

The Interlaboratory Robustness Of Next-Generation Sequencing (IRON) Study Phase II: Deep-Sequencing Analyses Of Hematological Malignancies Performed In 8,867 Cases By An International Network Involving 27 Laboratories

Blood (2013) 122 (21): 743.

https://doi.org/10.1182/blood.V122.21.743.743

Published: 2013

Journal Articles

The Interlaboratory Robustness of Next-Generation Sequencing (IRON) Study Phase II: Deep-Sequencing Analyses of Hematological Malignancies Performed by an International Network Involving 26 Laboratories

Blood (2012) 120 (21): 1399.

https://doi.org/10.1182/blood.V120.21.1399.1399

Published: 2012

Journal Articles

International Standardization of Minimal Residual Disease Assessment for in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) Expressing m-BCR-ABL Transcripts: Updated Results of Quality Control Procedures by the EWALL and ESG-MRD-ALL Consortia

Blood (2011) 118 (21): 2535.

https://doi.org/10.1182/blood.V118.21.2535.2535

Published: 2011

Journal Articles

Stability of Conversion Factors for BCR-ABL Monitoring -– Implications for the Frequency of Validation Rounds

Martin C. Müller, MD, Umang Munjal, PhD, Philipp Erben, MD, Thomas Lion, MD, PhD, Gerlinde Mitterbauer-Hohendanner, MD, Hakim El Housni, MD, Nancy Boeckx, Renata Zadro, MD, PhD, Jiri Mayer, MD, PhD, Peter Rohon, MD, Jana Rulcova, PhD, Lykke Grubach, Kadri Raudsepp, MD, Veli Kairisto, MD, PhD, Francois-Xavier Mahon, MD, PhD, Claude Preudhomme, MD, Sandrine Hayette, MD, Jean Gabert, MD, Jean-Michel Cayuela, MD, PhD, Christian Thiede, Lars Galonska, MD, Heike Pfeifer, MD, Carsten Hirt, MD, Philippe Schafhausen, MD, Nils von Neuhoff, PhD, Martin Roskos, MD, Christiane Pott, MD, Thoralf Lange, MD, Georg Hess, MD, Susanne Schnittger, PhD, Annika Dufour, MD, Steffen Koschmieder, MD, Frank Stegelmann, MD, Katerina Zoi, MD, PhD, Kostas Stamatopoulos, Hajnalka Andrikovics, MD, PhD, Tali Tohami, MD, PhD, Giovanni Martinelli, MD, Barbara Izzo, PhD, Enrico Gottardi, MD, Mindaugas Stoskus, Dag Andre Nymoen, MD, Tomasz Sacha, MD, Joana Diamond, MD, PhD, Rodica Talmaci, PhD, Andrey Misyurin, MD, Michael V. Dubina, MD, Tadej Pajic, MD, PhD, Josep F. Nomdedeu, MD, Dolors Colomer, MD, PhD, Gisela Barbany-Bustinza, MD, Hans Ehrencrona, MD, Elisabeth Oppliger Leibundgut, PhD, Jeroen Janssen, MD, Vincent H. J. van der elden, MD, Peter J.M. Valk, MD, PhD, Ugur Ozbek, MD, PhD, Lihui Wang, Gareth Gerrard, PhD, Helen E White, PhD, Thomas Schenk, MD, Thomas Ernst, MD, Rüdiger Hehlmann, MD, Giuseppe Saglio, MD, PhD, Andreas Hochhaus, MD, Nicholas C. P. Cross, PhD

Blood (2010) 116 (21): 893.

https://doi.org/10.1182/blood.V116.21.893.893

Published: 2010

Journal Articles

Harmonized Testing for BCR-ABL Kinase Domain Mutations In CML: Results of a Survey and First Control Round within 28 National Reference Laboratories In Europe

Blood (2010) 116 (21): 894.

https://doi.org/10.1182/blood.V116.21.894.894

Published: 2010

Journal Articles

Proliferation Kinetics of Subclones Carrying Point Mutations In the BCR-ABL TKD During TKI Treatment In CML Patients: Quantitative Monitoring by LD-PCR

Sandra Preuner, Margit Bernroitner, PhD, Gerlinde Mitterbauer, MD, Christine Mannhalter, PhD, Susanne Herndlhofer, MD, Wolfgang R Sperr, MD, Gerald Webersinke, PhD, Peter Valent, MD, Thomas Lion, MD, PhD

Blood (2010) 116 (21): 2269.

https://doi.org/10.1182/blood.V116.21.2269.2269

Published: 2010

Journal Articles

Diagnosis of Invasive Fungal Infections by a Real-Time Panfungal PCR Assay in Pediatric Patients Undergoing Intensive Chemotherapy or Allogeneic Stem Cell Transplantion.

Christine Landlinger, PhD, Lenka Baskova, Sandra Preuner, Martine Van Grotel, MD, Nico G. Hartwig, Marry M. van den Heuvel, MD, PhD, Thomas Lion, MD, PhD

Blood (2009) 114 (22): 343.

https://doi.org/10.1182/blood.V114.22.343.343

Published: 2009

Journal Articles

Multicenter, Randomized, Phase III Study Comparing Imatinib (Glivec) Standard Dose (400 mg/d) with Imatinib High Dose Induction (800 mg/d) Followed by Imatinib Maintenance (400 mg/d) in Patients with Pretreated Ph + /BCR-ABL + CML in Chronic Phase - Results from the First Planned Interim Analysis (CELSG-CML 11 ISTAHIT Study).

Andreas L. Petzer, MD, Dominik Wolf, MD, Dominik Fong, MD, Thomas Lion, MD, PhD, Irina Dyagil, MD, Zvenyslava Masliak, MD, Darinka Boskovic, MD, Laimonas Griskevicius, MD, Sandra Lejniece, MD, Emil Spasov, MD, Liana Gercheva, MD, Aleksandar Stojanovic, MD, Dontcho Peytchev, MD, Nikolay Tzvetkov, MD, Rasa Griniute, MD, Atanas Stanchev, MD, Martin Kwakkelstein, MD, Hanno Ulmer, PhD, Guenther A. Gastl, MD

Blood (2007) 110 (11): 1048.

https://doi.org/10.1182/blood.V110.11.1048.1048

Published: 2007

Journal Articles

A Prospective Gene Expression Profiling Study for Prediction of Cytogenetic Response in Early and Late Chronic Phase CML.

Dominik Wolf, MD, Stefan U. Schmidt, MD, Dominik Fong, MD, Oliver Wrulich, PhD, Thomas Lion, MD, PhD, Florian Überall, PhD, Andreas Petzer, MD, Günther Gastl, MD

Blood (2007) 110 (11): 2916.

https://doi.org/10.1182/blood.V110.11.2916.2916

Published: 2007

Journal Articles

Treatment Response and Outcome in Childhood t(1;19)/ TCF3-PBX1 Positive Acute Lymphoblastic Leukemia: A Report from the Austrian BFM Group.

Leo Kager, MD, Thomas Lion, MD, PhD, Andishe Attarbaschi, MD, Margit Koenig, PhD, Sabine Strehl, PhD, Oskar A. Haas, MD, Michael N. Dworzak, MD, Martin Schrappe, MD, PhD, Helmut Gadner, MD, Georg Mann, MD

Blood (2005) 106 (11): 1458.

https://doi.org/10.1182/blood.V106.11.1458.1458

Published: 2005

Journal Articles

Molecular Diagnosis of Invasive Fungal Infections: Species Identification and Quantitative Analysis by Broad-Spectrum PCR Assays.

Lenka Baskova, MS, Sandra Preuner, Thomas Lion, MD, PhD

Blood (2005) 106 (11): 5339.

https://doi.org/10.1182/blood.V106.11.5339.5339

Published: 2005

Journal Articles

Molecular Serotype Analysis of Adenoviruses: Clinical Implications.

Thomas Lion, MD, PhD, Karin Ebner, MS, Susanne Matthes-Martin, MD, Franz Watzinger, PhD

Blood (2004) 104 (11): 2237.

https://doi.org/10.1182/blood.V104.11.2237.2237

Published: 2004

Journal Articles

Pcr-Screening for Viral Infections during Allogeneic Stem Cell Transplantation: Clinical Benefit and Economic Consideration.

Susanne Matthes-Martin, MD, Thomas Lion, MD PhD, Anita Lawitschka, MD, Brigitta Keck, MD, Susanne Karlhuber, MD, Helmut Gadner, MD, Christina Peters, MD

Blood (2004) 104 (11): 2240.

https://doi.org/10.1182/blood.V104.11.2240.2240

Published: 2004

NARROW

A Novel Fusion Gene NDEL1-Pdgfrb in a Patient with JMML with a New Variant of TKI-Resistant Mutation in the Kinase Domain of PDGFRβ

Rapid Identification Of Compound Mutations In Patients With Ph-Positive Leukemias By Long-Range Next Generation Sequencing

The Interlaboratory Robustness Of Next-Generation Sequencing (IRON) Study Phase II: Deep-Sequencing Analyses Of Hematological Malignancies Performed In 8,867 Cases By An International Network Involving 27 Laboratories

The Interlaboratory Robustness of Next-Generation Sequencing (IRON) Study Phase II: Deep-Sequencing Analyses of Hematological Malignancies Performed by an International Network Involving 26 Laboratories

International Standardization of Minimal Residual Disease Assessment for in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) Expressing m-BCR-ABL Transcripts: Updated Results of Quality Control Procedures by the EWALL and ESG-MRD-ALL Consortia

Stability of Conversion Factors for BCR-ABL Monitoring -– Implications for the Frequency of Validation Rounds

Harmonized Testing for BCR-ABL Kinase Domain Mutations In CML: Results of a Survey and First Control Round within 28 National Reference Laboratories In Europe

Proliferation Kinetics of Subclones Carrying Point Mutations In the BCR-ABL TKD During TKI Treatment In CML Patients: Quantitative Monitoring by LD-PCR

Diagnosis of Invasive Fungal Infections by a Real-Time Panfungal PCR Assay in Pediatric Patients Undergoing Intensive Chemotherapy or Allogeneic Stem Cell Transplantion.

A Prospective Gene Expression Profiling Study for Prediction of Cytogenetic Response in Early and Late Chronic Phase CML.

Treatment Response and Outcome in Childhood t(1;19)/ TCF3-PBX1 Positive Acute Lymphoblastic Leukemia: A Report from the Austrian BFM Group.

Molecular Diagnosis of Invasive Fungal Infections: Species Identification and Quantitative Analysis by Broad-Spectrum PCR Assays.

Molecular Serotype Analysis of Adenoviruses: Clinical Implications.

Pcr-Screening for Viral Infections during Allogeneic Stem Cell Transplantation: Clinical Benefit and Economic Consideration.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only